Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Surrozen Inc SRZN

Healthcare Biotechnology
Surrozen, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a range of organs and tissues. The Company is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with a current focus on severe liver... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SRZN)

Surrozen to Present at Upcoming Healthcare Investor Conferences

GlobeNewswire November 6, 2024

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

GlobeNewswire November 6, 2024

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

GlobeNewswire November 4, 2024

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

GlobeNewswire September 24, 2024

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

GlobeNewswire August 12, 2024

Surrozen Publishes Study in 'eLife' Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

GlobeNewswire June 12, 2024

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

GlobeNewswire June 10, 2024

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

GlobeNewswire June 4, 2024

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting

GlobeNewswire May 9, 2024
View More News ››

Opinion & Analysis (NDAQ:SRZN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SRZN)

How To Trade (SRZN)

NEWS: $SRZN How To Trade (SRZN)2024-10-15 16:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method...
whytestocks - October 15, 2024

Surrozen, Inc. (NASDAQ:SRZN): A Promising Biotech Poised for

http://beyondspx.com/2024/08/02/surrozen-inc-nasdaqsrzn-a-promising-biotech-poised-for-breakthrough-therapies/
MikeTester - August 3, 2024

Surrozen Publishes Study in 'eLife' Demonstrating the Promis

Breaking News: $SRZN Surrozen Publishes Study in 'eLife' Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique...
whytestocks - June 12, 2024

Objective long/short (SRZN) Report

News; $SRZN Objective long/short (SRZN) Report2024-03-07 20:20:00 ET Stock Traders Daily has produced this trading report using a...
whytestocks - March 7, 2024
View more Bullboard ››

Eastern Platinum Ltd.

Eastern Platinum Ltd.

Eastern Platinum Limited owns directly and indirectly a number of platinum group metals (PGM) and chrome assets in the ...
View More »